Compare Dicks Sporting Goods Inc (DKS) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dicks Sporting Goods Inc vs Medpace Holdings Inc — how do they compare? Dicks Sporting Goods Inc trades at $136.65 (market cap $13.26B), while Medpace Holdings Inc trades at $612.05 (market cap $16.82B). The key difference: Medpace Holdings Inc is the larger of the two by market cap, and Dicks Sporting Goods Inc pays a 3.71% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dicks Sporting Goods Inc for 19 Days and Medpace Holdings Inc for 14 Days on average.
| DKS | MEDP | |
|---|---|---|
Market Cap | $13.26B | $16.82B |
Volume | 2,292,035 | 223,093 |
Sector | Consumer Cyclical | Health |
52-Week High | $239.17 | $630.19 |
52-Week Low | $121.15 | $393.42 |
Typical Hold Time | 19 Days | 14 Days |
Enterprise Value | $20.31B | $16.44B |
Dividend Yield | 3.71% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DICK'S Sporting Goods (DKS) trades at $136.65, up 4.17% today, with a bearish technical signal but strong fundamentals including a P/E of 14.86 and ROE of 18.47%. Recent earnings show mixed results, with Q2 2026 missing estimates, while Q3 2026 results are pending. The company faces a securities class action lawsuit, with multiple law firms alerting investors of a November 2026 deadline, contributing to negative sentiment despite a dividend announcement of $1.25 payable in September 2026.
The outlook is cautious due to legal overhangs and a bearish technical trend, but valuation metrics remain attractive. Upside exists if the company exceeds Q3 earnings expectations and resolves legal issues. Key risks include the class action lawsuit, competitive pressures, and potential margin compression from increased investing activities. Analyst consensus is bullish with a $153.30 price target, suggesting 12% upside from current levels.
MEDP trades at $612.05, up 1.29% today, near its consensus price target of $620.44. The stock shows strong profitability with a 17.67% net margin and has beaten earnings estimates for the last three quarters. Technical indicators are neutral overall, with support at $595 and resistance at $612. Recent news highlights CEO stock sales and institutional position changes, while the company prepares to report Q3 2026 results on October 21.
Outlook remains positive given consistent earnings beats and projected revenue growth to $2.8B in 2026. Risks include high valuation multiples (P/E 35.41) and insider selling. Analyst consensus is cautious with 79% hold ratings, suggesting limited near-term upside but solid fundamental support for long-term holders.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dicks Sporting Goods Inc
Dick's Sporting Goods is a leading omni-channel sporting goods retailer in the US It offers an extensive assortment of authentic sports equipment, apparel, footwear, and accessories through its stores and digital platforms.
Read more on DKS →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
